Us Physicalrapy Stock Net Income

USPH Stock  USD 76.04  0.13  0.17%   
US Physicalrapy fundamentals help investors to digest information that contributes to US Physicalrapy's financial success or failures. It also enables traders to predict the movement of USPH Stock. The fundamental analysis module provides a way to measure US Physicalrapy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to US Physicalrapy stock.
Last ReportedProjected for Next Year
Net Income45.6 M47.9 M
Net Income Applicable To Common Shares33.7 M19.8 M
Net Income From Continuing Ops45.6 M42.9 M
Net Income Per Share 1.76  0.94 
Net Income Per E B T 0.44  0.64 
As of now, US Physicalrapy's Net Income is increasing as compared to previous years. The US Physicalrapy's current Net Income Per E B T is estimated to increase to 0.64, while Net Income Applicable To Common Shares is projected to decrease to under 19.8 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

US Physicalrapy Company Net Income Analysis

US Physicalrapy's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current US Physicalrapy Net Income

    
  45.6 M  
Most of US Physicalrapy's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, US Physicalrapy is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

USPH Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for US Physicalrapy is extremely important. It helps to project a fair market value of USPH Stock properly, considering its historical fundamentals such as Net Income. Since US Physicalrapy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of US Physicalrapy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of US Physicalrapy's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

USPH Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

2.63 Million

As of now, US Physicalrapy's Accumulated Other Comprehensive Income is increasing as compared to previous years.
Based on the recorded statements, US Physicalrapy reported net income of 45.6 M. This is 86.64% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 92.01% higher than that of the company.

USPH Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses US Physicalrapy's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of US Physicalrapy could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics of similar companies.
US Physicalrapy is currently under evaluation in net income category among its peers.

US Physicalrapy ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, US Physicalrapy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to US Physicalrapy's managers, analysts, and investors.
Environmental
Governance
Social

US Physicalrapy Institutional Holders

Institutional Holdings refers to the ownership stake in US Physicalrapy that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of US Physicalrapy's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing US Physicalrapy's value.
Shares
Gw&k Investment Management, Llc2024-12-31
316.2 K
Riverbridge Partners Llc2024-12-31
310.2 K
Envestnet Asset Management Inc2024-12-31
299.8 K
Northern Trust Corp2024-12-31
261.8 K
Bahl & Gaynor Inc.2024-12-31
260.1 K
Point72 Asset Management, L.p.2024-12-31
212.9 K
Silvercrest Asset Management Group Llc2024-12-31
189.1 K
Rockefeller Capital Management L.p.2024-12-31
188.3 K
Fmr Inc2024-12-31
165.7 K
Blackrock Inc2024-12-31
2.3 M
Vanguard Group Inc2024-12-31
1.1 M

USPH Fundamentals

About US Physicalrapy Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out US Physicalrapy Piotroski F Score and US Physicalrapy Altman Z Score analysis.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Dividend Share
1.76
Earnings Share
1.84
Revenue Per Share
44.107
Quarterly Revenue Growth
0.166
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.